As the litigation develops, the central focus remains whether manufacturers provided adequate warnings about the potential risk of serious gastrointestinal side effects
doi: 10.1111/dom.12085 [DOI] [PubMed] [Google Scholar] 60.Ribeiro-Silva JC, Tavares CAM, Girardi ACC
But heres what we know from recent research: A 2025 study presented at ENDO showed that postmenopausal women using tirzepatide plus hormone replacement therapy (HRT) lost significantly more weight (17% total body weight) compared to women using tirzepatide alone (14%)
I think the policy challenge isnt whether to use GLP-1s, but how to do so in a more equitable and sustainable way. Jaime Almandoz GLP-1s Are Expensive, But Changes Are Coming It is often reported that GLP-1 drugs can cost more than $1,000 a month
However, typical titration schedules start with a lower dose and gradually increase the medication dose over several weeks
Initial management involves confirming the heart rate elevation through repeated measurements and excluding other contributing factors